Feb. 18, 2013
/PRNewswire-USNewswire/ -- The Barbara Ann Karmanos Cancer Institute has announced the successful completion of the
Herrick Cancer Research Challenge, with an approximately
total impact, exceeding challenge goals. The total impact includes grant dollars contributed by the Herrick Foundation and challenge funds given by donors.
The Herrick Foundation made an initial donation of
in 2009 to launch the challenge, which specified that up to
additional dollars would be matched if the additional monies could be raised by Karmanos Cancer Institute over four years. Challenge funds have supported various areas of research at Karmanos, including the Institute's National Oncogenomics and Molecular Imaging Center, pediatric leukemia, lung cancer, new imaging technologies for cancer detection and treatment, and prostate cancer.
"We are thrilled to have successfully met the Herrick Cancer Research Challenge by surpassing our fundraising goals to support the innovative research programs at Karmanos," said
, M.D., Ph.D., president and CEO of Karmanos. "We thank the Herrick family for their extremely generous gift of
and our other thoughtful donors who helped us meet the challenge.
"Because of this combined support, our scientific researchers can advance their important work in developing new therapies and cutting-edge cancer detection technologies, which include the pursuit of personalized medicine for the benefit of our patients."
One specific area Herrick Challenge funds helped to support is in prostate cancer research. Researchers at Karmanos and
Wayne State University
School of Medicine are investigating this form of cancer and the racial disparities behind more aggressive and recurrent prostate cancer. They are using DNA and serum samples from patients to study the association between metabolic syndrome and aggressive prostate cancer. Metabolic syndrome is a cluster of conditions that include increased blood pressure, elevated insulin levels, excess body fat around the waist or abnormal cholesterol levels, which occur together, increasing a person's risk of disease, including aggressive prostate cancer.
The project goal is to develop a way to detect prostate cancer early and to understand its likelihood of recurrence considering prostate cancer is the most prevalent cancer in men. Herrick Funds also have helped to add new research jobs at Karmanos in association with this project and allowed researchers to secure additional, harder-to-obtain funding to continue their work.